Features | Partner Sites | Information | LinkXpress
Sign In
ElsMed
Ampronix
Schiller

Helium Ions May Provide Better-Targeted Treatment in Pediatric Radiotherapy

By Medimaging International staff writers
Posted on 14 Apr 2014
Scientists have for the first time been able to demonstrate that the use of helium ions in radiotherapy could deliver effective treatment to tumors while sparing healthy organs.

The treatment planning study’s findings were presented at the European Society of radiotherapy & Oncology (ESTRO) 33 Congress, held April 4–8, 2014, in Vienna (Austria), has been able to show that helium may have effects that are superior to radiotherapy using protons, which is a considerable advance on traditional photon beam radiotherapy.

Hermann Fuchs, a PhD student at the Medical University of Vienna/AKH (Austria), working with Dr. Barbara Knäusl and Prof. Dietmar Georg, set out to devise a way of calculating the optimal dose of helium ions for use in radiation treatment. The dose calculation algorithm was then used for treatment plan calculation for 10 pediatric patients, five with neuroblastoma (tumors arising in cells of the hormonal and nervous system), and five with Hodgkin’s lymphoma (a cancer of the white blood cells).

“Particle beam therapy involving protons or carbon ions has advantages over conventional radiotherapy. Helium ions may represent another kind of particle that can improve radiotherapy treatment. Due to their increased mass, spreading of the beam is reduced by a factor of two as compared with protons. Moreover helium ions have an increased biological effectiveness at the end of their range,” Mr. Fuchs explained.

Heavier ions such as carbon have the potential to kill cancer cells more effectively due to their underlying biology. But by modelling these biologic processes, a number of unknowns are introduced, and these can be reduced by using lighter ions such as helium. “Helium ions reside in the low linear energy transfer [LET] area,” said Mr. Fuchs. “LET is a physical quantity describing how much energy of a particle is deposited at a given range, and this measure is important when looking at the biological effects of therapy.”

This greater accuracy and sparing of healthy tissue is essential in the case of children, the researchers reported. When treating them it is especially important to ensure that as little dose of radiation as possible is placed outside the area to be treated, because an increased area treated with a low dose can lead to the development of secondary tumors. Given that children have a potentially long lifespan ahead of them, this probability needs to be reduced as much as possible through the use of therapies that are targeted as precisely as possible to the tumor, while sparing the dose to neighboring areas, and especially to healthy organs particularly sensitive to radiation located nearby (the organs at risk).

“After three years of extensive research and validation efforts, we were able to produce a treatment planning algorithm that enabled us to investigate the possibilities for using helium ion therapy in children treated with low dose radiation. We would now like to investigate its potential in patients being treated with higher doses, for example, those with brain tumors. The good results that have been achieved so far warrant the verification of the model in order to investigate the real clinical potential of helium ions,” Mr. Fuchs said. “In the long term, clinical trials of this therapy will be needed to substantiate the effects of our treatment planning model. “Particle beam therapy has already advanced care and treatment options for cancer patients. We hope that the use of helium ions may help to bring about further improvements.”

President of ESTRO, Prof. Vincenzo Valentini, a radiation oncologist at the Policlinico Universitario A. Gemelli (Rome, Italy), commented, “This is an exciting study that holds out hope for improved, more accurate radiation treatment for young cancer patients.”

Related Links:

Medical University of Vienna/AKH



Channels

Radiography

view channel
Image: Agfa HealthCare’s DX-D Mobile Retrofit solution will allow hospitals an easy and affordable way to upgrade existing GE Healthcare’s AMX 4 and 4 plus mobile X-ray systems to direct radiography (DR) (Photo courtesy of Agfa Healthcare).

Retrofit Enables Cost-Effective Upgrade of Existing Mobile X-Ray Systems to Direct Radiography

A mobile retrofit system has been designed to be mounted on mobile X-ray systems to create an easy way for hospitals to go digital without having to replace existing mobile X-ray units. A direct radiography... Read more

MRI

view channel
Image: The ischemic penumbra is visible in some patients up to 24 hour after stroke by MRI scanning. Perfusion-weighted imaging can be used to show areas of ischemia and can be compared with the ischemic core, visible by diffusion-weighted imaging (Photo courtesy of sharinginginhealth dot ca, an open access training in healthcare resource).

Diffusion-Weighted MRI Becoming Major Tool to Diagnose Patients with Transient Ischemic Attacks

With the development of brain imaging, including cranial computed tomography (CCT), and particularly diffusion-weighted imaging-magnetic resonance imaging (DWI-MRI), the diagnosis of transient ischemic... Read more

Ultrasound

view channel
Image: Ultrasound image of the Circle of Willis (Photo courtesy of the Swedish Cerebrovascular Center, Seattle, WA, USA).

New Approaches for Transcanial Ultrasound Used for the Treatment of Brain Tumors and Targeted Drug Delivery

A study completed by a Finnish researcher provides new insights into the limitations and potential new directions for the future advancement of transcranial ultrasound therapy. Active research is ongoing... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.